 |
Our Newly Discovered Metabolic Networks |
|
Our current primarily research and
development focuses on applications resulting from newly
discovered metabolic networks in humans. Our newly discovered biochemical pathways and their regulatory systems are capable of producing numerous advanced and/or novel products and services, including those relative to areas such as therapeutics, diagnostics and research tools. Although there are numerous applications for our newly discovered networks and the biochemical pathways involved with them, our current primary research, development and business activities at this point in time are focused on products and services relative to the therapeutics industry. New Understandings Of MetabolismIt is both interesting and important to note that in order for the new networks and pathways to be activated and utilised very specific predetermining factors must first eventuate. As such, the new networks and pathways somewhat fall outside of conventionally established understandings of metabolism. And, it is for these reasons that not only are the new networks and pathways not readily detectable by conventional means but also why they have remained previously undiscovered. Due to our ongoing research efforts we have been able to successfully map out the relevant predetermining factors and have commenced developing exact methods for readily and easily establishing both the utilisation of these predetermining factors as well as the utilising of each new network of metabolic pathways and other general cellular systems and processes. Having said all of this, the vast array of previously unknown biochemical pathways that we have discovered now allow for a vast array of new methods of protein synthesis, protein degradation and protein recycling. What's more, in many instances these methods and the biological systems that they utilise also allow for far more highly targeted cell receptor binding, epigenetic functioning and general signal transduction. New Therapeutic CapabilitiesOur new methods, as just previously described, and the mechanisms that control them can be utilised to directly influence how the biochemistry and general biological functioning of the human body operate, thus also directly influencing the results therapeutic methods produce. Essentially, one of the main ways in which the newly discovered networks function is that of acting as alternative networks and pathways for interrelated biological functioning. Whilst they still produce almost identical biochemical end products and/or general cellular outcomes, one of the only major difference we have identified thus far is that some of the new pathways are far more reactive and/or powerful in their metabolic and cellular abilities than currently known pathways whilst others are somewhat weaker. However, we have also found that some of the new metabolic networks act as complete substitutes for currently known networks and both their interrelated and directly associated biological functioning. Thus far we have discovered the workings of up to 2 new metabolic networks for many of the main functions in the human body and their already established biochemical systems. Furthermore, we have also discovered that many of the new biochemical pathways are coupled to existing pathways. Having said this, what we have also discovered is that many of the new pathways can be synergistically coordinated with currently established pathways and related therapeutics so as to provide for not only far more amplified treatment outcomes but also far more overall comprehensive and versatile treatment outcomes. Having said all of this so far, these new networks and pathways can be utilised to develop literally hundreds, if not thousands, of new therapeutics that target the same systems as current therapeutics (and their diagnostics procedures) but simply via new pathways, receptors, cellular processes, biomarkers and so on. What's more, many new treatments can also now be devised for medical conditions that had previously only ever been theorised about but never properly substantiated or proven. All this, in turn, is serving to substantially help fill the gaps in a wide array of unmet therapeutic needs. Furthermore to all this, utilising the mechanisms involved here, many new diagnostics procedures and research tools can also be developed to fill the gaps in a wide array of unmet diagnostic and research needs. A New Delivery SystemWhat we have also discovered is that most all side effects and other general complications and inadequacies associated with most all therapeutic substances are actually the result of these substances being assimilated and utilised in conflict with many of our newly discovered pathways and their general regulatory and cellular systems. However, our ongoing research investigations have allowed us to also develop a delivery system that can correctly assimilate any substance without any conflicts occurring. This, in turn, ensures that the body not only utilises the substances far more effectively and efficiently but also far more accurately. Due to our delivery system, most all side effects and other general inadequacies can now be substantially controlled and/or minimised, and, in many instances, even completely eradicated. As a further extension of all of this, we have also discovered that it is because of our newly discovered networks and their general regulatory and cellular systems that many substances do not function as predicted. In some cases it is because the substances are in conflict with the newly discovered networks and their cellular systems whilst in other cases it is because they are actually working within the newly discovered systems but not being assimilated correctly (thus, not utilising the mechanisms of our newly established delivery system). Having said all of this, thus far we have been able to assessed over 200 substances (pharmaceutical, nutraceutical, phytoceutical and zooceutical) and worked out how to make them far more safer, effective and efficient. Other New Understandings & ApplicationsFrom our initial discoveries a number of other related and interrelated aspects have also been discovered, including being able to better confirm a number of biological theories as well as establishing new understandings of a number of already known biological workings. As an example of all this, and of particular interest and importance, is that in relation to cell receptor functioning and dysfunction (and especially certain types of cell receptors). In this instance, what we have now discovered is how to recalibrate and/or boost dysfunctional receptors so as to not only increase their activity levels but also, where applicable, inhibit such things as autoimmune responses to the cells caused by receptor dysfunction lending to general cellular dysfunction. We have already commenced utilising our overall new findings to develop a number of new and/or advanced diagnostic procedures, research tools, medical treatments and so on. In fact, it is important to note that our discoveries can be incorporated into the main research and development processes involved with just about any other type of medical science so as to greatly refine and enhance these processes for much faster, more reliable and more highly defined results. |
|
| .......................................... | |
| Members Area | |
| Retrieve Password | |
| Menu | |
 |
Introduction |
|
|
Our Newly Discovered Metabolic Networks |
|
|
Our Metabolic Amplification Platform Technology |
|
|
Nutraceutical Applications |
|
|
Pharmaceutical Applications |
|
|
Phytoceutical Applications |
|
|
Zooceutical Applications |
|
|
R & D Applications |
|
|
Diagnostic Applications |
|
|
Our Medical Treatments |
|
|
Advanced Hydrocolloids |
|
|
Partnering With Us |
|
|
Technology Pipeline |